Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: Meet Wegovy pill · annual-results still. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The headline, Meet the Wegovy pill, works like a launch announcement, and for someone who's been waiting for a pill instead of an injection that's news worth stopping for. The two claim cards are short and specific, with the study details and a your results may vary line printed on the same frame. The giant pills make the product the whole scene, so nobody has to guess what's being announced. Ro started running it on Meta on October 20, 2026.
There's no person in it and no reason to choose Ro over anywhere else that offers the same pill, apart from the lowest-cost line, which doesn't come with a price. The ad assumes the viewer already wants a pill. If you make a launch ad like this, add the price next to the cost claim and pair the motion graphic with a creator version that explains why a pill matters to them (no needles, easier routine).
It frames the ad as a launch, which gives people a reason to stop.
Two short claims give the viewer the main reasons to care, with the conditions on the same frame.
It closes with a credibility marker and a low-commitment next step.
The required safety copy ends the ad.
A claim that it's the lowest-cost FDA-approved GLP-1, with no price shown. The copy notes that medication and membership terms apply.
The click lands on Ro's weight-loss quiz entry, which the persona's landing-page ladder puts above a homepage or a basic product page. The page opens with the headline Lose weight on Ro, a photo of Serena Williams labeled as a Ro member, and a card asking which Ro option you're interested in (GLP-1 pill, GLP-1 shot, learn about both, or a provider recommendation), with a banner up top claiming the lowest GLP-1 prices are on Ro. The page's first option, GLP-1 pill, matches the ad exactly, so someone who wants the pill can say so in one tap. That's a good handoff, even though the captured screen doesn't mention the Wegovy pill by name.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.